Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Artivion, Inc.

CRYNYSE
Healthcare
Medical - Devices
$17.88
$0.25(1.42%)
U.S. Market is Open • 14:07

Artivion, Inc. Fundamental Analysis

Artivion, Inc. (CRY) shows weak financial fundamentals with a PE ratio of 87.06, profit margin of 2.21%, and ROE of 2.44%. The company generates $0.4B in annual revenue with moderate year-over-year growth of 9.75%.

Key Strengths

No significant strengths identified.

Areas of Concern

ROE2.44%
Operating Margin7.65%
Current Ratio0.00
We analyze CRY's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 33.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
33.7/100

We analyze CRY's fundamental strength across five key dimensions:

Efficiency Score

Weak

CRY struggles to generate sufficient returns from assets.

ROA > 10%
0.00%

Valuation Score

Moderate

CRY shows balanced valuation metrics.

PE < 25
87.06
PEG Ratio < 2
1.74

Growth Score

Excellent

CRY delivers strong and consistent growth momentum.

Revenue Growth > 5%
9.75%
EPS Growth > 10%
57.33%

Financial Health Score

Moderate

CRY shows balanced financial health with some risks.

Debt/Equity < 1
0.02
Current Ratio > 1
0.00

Profitability Score

Moderate

CRY maintains healthy but balanced margins.

ROE > 15%
244.04%
Net Margin ≥ 15%
2.21%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is CRY Expensive or Cheap?

P/E Ratio

CRY trades at 87.06 times earnings. This suggests a premium valuation.

87.06

PEG Ratio

When adjusting for growth, CRY's PEG of 1.74 indicates fair valuation.

1.74

Price to Book

The market values Artivion, Inc. at 1.90 times its book value. This may indicate undervaluation.

1.90

EV/EBITDA

Enterprise value stands at 21.25 times EBITDA. This signals the market has high growth expectations.

21.25

How Well Does CRY Make Money?

Net Profit Margin

For every $100 in sales, Artivion, Inc. keeps $2.21 as profit after all expenses.

2.21%

Operating Margin

Core operations generate 7.65 in profit for every $100 in revenue, before interest and taxes.

7.65%

ROE

Management delivers $2.44 in profit for every $100 of shareholder equity.

2.44%

ROA

Artivion, Inc. generates $0.00 in profit for every $100 in assets, demonstrating efficient asset deployment.

0.00%

Following the Money - Real Cash Generation

Operating Cash Flow

Artivion, Inc. generates limited operating cash flow of $34.01M, signaling weaker underlying cash strength.

$34.01M

Free Cash Flow

Artivion, Inc. generates weak or negative free cash flow of $715.45K, restricting financial flexibility.

$715.45K

FCF Per Share

Each share generates $0.02 in free cash annually.

$0.02

FCF Yield

CRY converts 0.12% of its market value into free cash.

0.12%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

87.06

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

1.74

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.90

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.64

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.02

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.00

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.02

vs 25 benchmark

ROA

Return on assets percentage

0.00

vs 25 benchmark

ROCE

Return on capital employed

-0.33

vs 25 benchmark

How CRY Stacks Against Its Sector Peers

MetricCRY ValueSector AveragePerformance
P/E Ratio87.0629.43 Worse (Expensive)
ROE2.44%800.00% Weak
Net Margin2.21%-20145.00% (disorted) Weak
Debt/Equity0.020.30 Strong (Low Leverage)
Current Ratio0.004.64 Weak Liquidity
ROA0.00%-17936.00% (disorted) Weak

CRY outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Artivion, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

25.28%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-791.74%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

25.13%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ